Controlling Microbial Growth in the Body: Antimicrobial Agents and Resistance

Controlling Microbial Growth in the Body

Introduction

This study guide covers the principles and mechanisms of antimicrobial agents, their history, and the development of antibiotic resistance. It is designed for college-level microbiology students preparing for exams or seeking a comprehensive overview of Chapter 10: Controlling Microbial Growth in the Body.

Learning Objectives

• Describe different mechanisms of action for antibiotics.

• Name the different mechanisms of antibiotic resistance.

• Explain how to test the efficacy of antimicrobial drugs.

What are Antimicrobial Agents?

Definition and Types

Antimicrobial agents are substances that affect the physiology of an organism, often by inhibiting or killing microbes. They are a subset of therapeutics, which are drugs that act against diseases.

• Antimicrobial agents: Drugs that treat infections by either killing or inhibiting the growth of microbes.

• Examples of non-antimicrobial agents: Caffeine, alcohol, nicotine (affect physiology but do not treat infections).

• Therapeutics: Includes drugs like statins (cholesterol), Nexium (acid reflux), Humira (autoimmune diseases).

Key Point: Antimicrobial agents specifically target infectious microbes, distinguishing them from other drugs that affect human physiology.

History of Antimicrobial Agents

Early Understanding and Milestones

The development of antimicrobial agents revolutionized the treatment of infectious diseases. Before their discovery, infectious diseases were a leading cause of death, especially among children.

• In the 16th and 17th centuries, the cause of infectious diseases was not understood.

• Robert Koch: Established the relationship between microbes and disease (germ theory).

• Despite Koch's discoveries, there were no effective treatments for infectious diseases.

• One-third of children born in some regions died from infectious diseases before the age of five.

Key Point: The lack of antimicrobial agents contributed to high mortality rates from infectious diseases prior to the 20th century.

Development of Antimicrobial Agents

Major Discoveries

• Paul Ehrlich: Coined the term "magic bullets" for compounds that selectively target pathogens. Developed Salvarsan, an arsenic-based compound effective against Treponema pallidum (syphilis).

• Alexander Fleming: Discovered penicillin, the first true antibiotic, produced by the fungus Penicillium.

• Florey, Chain, and Heatley: Developed penicillin into a mass-producible drug.

• Gerhard Domagk: Discovered sulfanilamide (Prontosil), the first commercially available synthetic antibiotic.

• Selman Waksman: Discovered that many antibiotics are produced by soil bacteria, such as Streptomyces (source of streptomycin).

Key Point: The discovery and development of antibiotics and synthetic antimicrobials transformed medicine and reduced mortality from infectious diseases.

Classification of Antimicrobial Agents

Types of Antimicrobials

• Antibiotics: Naturally produced by microorganisms to kill or inhibit other microbes.

• Synthetic drugs: Completely synthesized in the laboratory.

• Semisynthetic drugs: Chemically altered antibiotics to improve efficacy or reduce side effects.

Key Point: Most antimicrobials in clinical use are either antibiotics or semisynthetic derivatives.

Mechanisms of Action of Antimicrobial Agents

Overview

Antimicrobial agents target specific structures or processes in microbes, exploiting differences between microbial and host cells.

• Cell wall synthesis inhibition

• Disruption of cytoplasmic membrane

• Inhibition of protein synthesis

• Inhibition of nucleic acid synthesis

• Inhibition of metabolic pathways

1. Inhibition of Cell Wall Synthesis

Bacterial cell walls are composed of peptidoglycan, a polymer of sugars (NAG and NAM) cross-linked by peptides. Drugs targeting cell wall synthesis are highly selective for bacteria.

• Peptidoglycan structure: Chains of N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM) linked by peptide crossbridges.

• Gram-positive bacteria: Thick peptidoglycan layer, teichoic acids, single membrane.

• Gram-negative bacteria: Thin peptidoglycan layer, outer membrane with lipopolysaccharides, two membranes.

• β-lactam antibiotics (e.g., penicillins, cephalosporins): Prevent cross-linking of NAM subunits, weakening the cell wall.

• Other agents: Isoniazid and ethambutol inhibit mycolic acid synthesis in mycobacteria (e.g., Mycobacterium tuberculosis).

• Echinocandins: Disrupt fungal cell wall biosynthesis by inhibiting glucan synthesis.

Example: Penicillin is effective against actively growing bacteria by inhibiting peptidoglycan synthesis.

2. Disruption of Cytoplasmic Membrane

Some antimicrobials form channels in microbial membranes, causing leakage and cell death. Fungal membranes contain ergosterol, a target for antifungal drugs.

• Polyenes (e.g., amphotericin B): Bind to ergosterol, forming pores in fungal membranes.

• Azoles: Inhibit ergosterol synthesis.

• Selective toxicity: Human cell membranes contain cholesterol, not ergosterol, making these drugs less toxic to humans.

Example: Amphotericin B is used to treat systemic fungal infections.

3. Inhibition of Protein Synthesis

Bacterial ribosomes (70S) differ from eukaryotic ribosomes (80S), allowing selective targeting by antibiotics.

• Aminoglycosides: Change the shape of the 30S subunit, causing misreading of mRNA.

• Tetracyclines: Block docking site of tRNA on the ribosome.

• Chloramphenicol: Blocks peptide bond formation.

• Macrolides: Block mRNA movement through the ribosome.

Example: Streptomycin is an aminoglycoside used to treat tuberculosis.

4. Inhibition of Nucleic Acid Synthesis

Some drugs interfere with DNA replication or RNA transcription, affecting both bacteria and viruses.

• Quinolones/Fluoroquinolones: Inhibit DNA gyrase, preventing DNA replication.

• Rifamycins: Bind to bacterial RNA polymerase, blocking transcription.

• Nucleotide/nucleoside analogs: Mimic natural nucleotides, causing premature chain termination (used against viruses).

Example: AZT (zidovudine) is a nucleoside analog used in HIV therapy.

5. Inhibition of Metabolic Pathways

Some antimicrobials block unique metabolic pathways in microbes.

• Sulfonamides: Inhibit folic acid synthesis in bacteria (humans obtain folic acid from diet).

• Trimethoprim: Blocks a later step in folic acid synthesis.

• Antiprotozoal agents: Disrupt tubulin or glucose metabolism in protozoa.

Example: Prontosil was the first commercial sulfonamide antibiotic.

Ideal Characteristics of Antimicrobial Agents

Desirable Properties

• Readily available

• Inexpensive

• Chemically stable

• Easily administered

• Non-toxic and non-allergenic

• Selectively toxic against a wide range of pathogens

Key Point: No drug is perfect; clinicians must weigh benefits and risks when choosing treatment.

Spectrum of Action

Broad vs. Narrow Spectrum

• Narrow-spectrum drugs: Effective against a limited group of organisms.

• Broad-spectrum drugs: Effective against a wide variety of organisms.

• Broad-spectrum drugs may disrupt normal flora, leading to secondary or superinfections.

Example: Broad-spectrum antibiotics can cause yeast infections by killing protective bacteria.

Antibiotic Resistance

Global Health Concern

Antibiotic resistance is rising worldwide, threatening the effectiveness of essential drugs. Surveillance data from the World Health Organization (WHO) show increasing resistance rates, emphasizing the need for prudent antibiotic use and development of new therapies.

• Laboratory-confirmed bacterial infections are increasingly resistant to antibiotics.

• Average annual increase in resistance is 5% among monitored antibiotic combinations.

• Antibiotic resistance poses a major threat to global health.

Key Point: Responsible use and ongoing research are critical to combat antibiotic resistance.

Testing the Efficacy of Antimicrobial Drugs

Methods

• Disk diffusion (Kirby-Bauer) test: Measures zone of inhibition around antibiotic disks on agar plates.

• Minimum inhibitory concentration (MIC): Lowest concentration of drug that prevents visible growth.

• Minimum bactericidal concentration (MBC): Lowest concentration that kills the organism.

Example: Petri dish assays are commonly used in clinical microbiology labs to assess drug efficacy.

Summary Table: Mechanisms of Action of Antimicrobial Agents

Mechanism	Target	Example Drugs	Notes
Cell Wall Synthesis Inhibition	Peptidoglycan (bacteria), glucan (fungi)	Penicillins, cephalosporins, echinocandins	Selective for microbes; ineffective against cells without walls
Cytoplasmic Membrane Disruption	Membrane sterols (ergosterol in fungi)	Polyenes, azoles	Targets unique fungal components
Protein Synthesis Inhibition	Ribosomes (70S in bacteria)	Aminoglycosides, tetracyclines, macrolides	Selective for bacterial ribosomes
Nucleic Acid Synthesis Inhibition	DNA/RNA polymerases	Quinolones, rifamycins, nucleotide analogs	Can affect both bacteria and viruses
Metabolic Pathway Inhibition	Enzymes unique to microbes	Sulfonamides, trimethoprim	Targets pathways absent in humans

Key Equations and Concepts

• Minimum Inhibitory Concentration (MIC): $MIC = \text{Lowest concentration of drug that inhibits visible growth}$

• Minimum Bactericidal Concentration (MBC): $MBC = \text{Lowest concentration of drug that kills 99.9\% of bacteria}$

Additional info: Some context and explanations have been expanded for clarity and completeness, including details on mechanisms, historical figures, and laboratory testing methods.